NewsNew combination drug LixiLan succeeds in phase III trialA new combination drug for type 2 diabetes, LixiLan has demonstrated positive…
NewsFirst CGM integrated touchscreen insulin pump approved by FDAThe t:slim G4 has become the first touchscreen insulin pump with integrated…
NewsSmokers with type 2 diabetes 50 per cent more likely to suffer heart problemsPatients with type 2 diabetes that smoke are 50% more likely to…
NewsType 2 diabetes prevention programme shows promiseA national programme designed to prevent the development of type 2 diabetes…
NewsShort bursts of intense exercise reverse heart abnormalities in people with type 2 diabetes, study findsShort bursts of intense exercise improves heart structure and improves diabetes control…
NewsTrans fats ban reduces rates of heart disease, study findsBanning trans fats does reduce rates of heart disease, according to new…
NewsType 1 diabetes trial patient insulin-free after treatmentA new type 1 diabetes trial has left one participant completely insulin-free.…
NewsHalf of all US adults have type 2 diabetes or prediabetes, study findsHalf of all US adults have either type 2 diabetes or prediabetes,…
NewsSanofis long-acting insulin Toujeo approved for use in ScotlandThe Scottish Medicines Consortium (SMC) has approved the use of Sanofi’s long-acting…
NewsDiabetes drug Victoza fails type 1 trialNovo Nordisk’s diabetes drug Victoza has failed a trial that assessed its…
